Artrya Statistics

Total Valuation

Artrya has a market cap or net worth of AUD 71.60 million. The enterprise value is 64.62 million.

Market Cap	71.60M
Enterprise Value	64.62M

Important Dates

The next estimated earnings date is Friday, May 23, 2025.

Earnings Date	May 23, 2025
Ex-Dividend Date	n/a

Share Statistics

Artrya has 112.76 million shares outstanding. The number of shares has increased by 2.07% in one year.

Current Share Class	n/a
Shares Outstanding	112.76M
Shares Change (YoY)	+2.07%
Shares Change (QoQ)	+3.72%
Owned by Insiders (%)	24.86%
Owned by Institutions (%)	3.54%
Float	75.43M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	5,507.67
PB Ratio	4.87
P/TBV Ratio	7.40
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-4.44
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-5.26

Financial Position

The company has a current ratio of 6.79, with a Debt / Equity ratio of 0.05.

Current Ratio	6.79
Quick Ratio	6.57
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	-0.06
Interest Coverage	-1,234.50

Financial Efficiency

Return on equity (ROE) is -75.75% and return on invested capital (ROIC) is -45.93%.

Return on Equity (ROE)	-75.75%
Return on Assets (ROA)	-43.33%
Return on Invested Capital (ROIC)	-45.93%
Return on Capital Employed (ROCE)	-97.69%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +104.84% in the last 52 weeks. The beta is 0.30, so Artrya's price volatility has been lower than the market average.

Beta (5Y)	0.30
52-Week Price Change	+104.84%
50-Day Moving Average	0.73
200-Day Moving Average	0.53
Relative Strength Index (RSI)	44.87
Average Volume (20 Days)	447,346

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Artrya had revenue of AUD 13,000 and -14.56 million in losses. Loss per share was -0.18.

Revenue	13,000
Gross Profit	-13.71M
Operating Income	-14.81M
Pretax Income	-14.55M
Net Income	-14.56M
EBITDA	-14.41M
EBIT	-14.81M
Loss Per Share	-0.18

Full Income Statement

Balance Sheet

The company has 7.76 million in cash and 789,000 in debt, giving a net cash position of 6.98 million or 0.06 per share.

Cash & Cash Equivalents	7.76M
Total Debt	789,000
Net Cash	6.98M
Net Cash Per Share	0.06
Equity (Book Value)	14.69M
Book Value Per Share	0.16
Working Capital	8.64M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -12.20 million and capital expenditures -74,000, giving a free cash flow of -12.28 million.

Operating Cash Flow	-12.20M
Capital Expenditures	-74,000
Free Cash Flow	-12.28M
FCF Per Share	-0.11

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-113,953.85%
Pretax Margin	-111,946.15%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Artrya does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.07%
Shareholder Yield	-2.07%
Earnings Yield	-20.34%
FCF Yield	-17.15%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Artrya has an Altman Z-Score of 1.14. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.14
Piotroski F-Score	n/a